Acupuncture for the Treatment of Interstitial Cystitis (IC) Symptoms
Interstitial Cystitis
About this trial
This is an interventional treatment trial for Interstitial Cystitis focused on measuring pelvic pain, bladder pain, urgency, frequency, nocturia
Eligibility Criteria
Inclusion Criteria: Age 18-65 years Symptomatic IC for at least six months Urinary frequency of at least eleven voids in a 24 hour period A self-rated global discomfort score of 4 or greater on a 0-10 scale Exclusion Criteria: Medical History or Co-Morbid Conditions: Any history of: bladder calculus, tuberculous cystitis; neurological disease or diabetic cystopathy; malignant bladder tumors, urethral cancer Prior 3 years of uterine, cervical or vaginal cancer (women only) Prior 6-12 weeks of: bacterial urinary tract infection; active genital herpes; gross hematuria Concurrent active urethral calculus, ureteral calculus, symptomatic urethral diverticulum; documented chronic bacterial prostatitis (men only); active vaginitis, pregnancy (women only) Prior and Concurrent Treatment for IC: Any history of: cyclophosphamide, pelvic radiation; augmentation cystoplasty, cystectomy or cystolysis, neurectomy, implanted peripheral nerve stimulator; prostate surgery or treatment (men only) In the prior 24 weeks: any treatment with intravesical BCG, cystocele, rectocele, urinary incontinence surgery, transvaginal surgery, hysterectomy, prolapse, vaginal delivery or C-section (women only) Prior 6-12 weeks: any treatment by urethral dilatation, cystometrogram, urodynamics, cystoscopy/hydrodistention, bladder biopsy; prostate biopsy (men only); any intravesical treatment other than BCG Prior 4 weeks: any new medications initiated for IC Concurrent intravesical heparin, chronic use of acetylsalicylic acid, non-steroidal anti-inflammatory drugs or opioid pain medications for another pain condition
Sites / Locations
- University of Pennsylvania Pain Medicine CenterRecruiting